Lysosomal acid glucosylceramidase
Also known as: GBA, GBA1, GC, GLUC
Function
Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramides/GlcCers (such as beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine) into free ceramides (such as N-acylsphing-4-enine) and glucose. Plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, participates in the PKC-activated salvage pathway of ceramide formation. Catalyzes the glucosylation of cholesterol, through a transglucosylation reaction where glucose is transferred from GlcCer to cholesterol. GlcCer containing mono-unsaturated fatty acids (such as beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4-enine) are preferred as glucose donors for cholesterol glucosylation when compared with GlcCer containing same chain length of saturated fatty acids (such as beta-D-glucosyl-N-octadecanoyl-sphing-4-enine). Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl 3-beta-D-glucoside to ceramide (Probable). Can also hydrolyze cholesteryl 3-beta-D-glucoside producing glucose and cholesterol. Catalyzes the hydrolysis of galactosylceramides/GalCers (such as beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine), as well as the transfer of galactose between GalCers and cholesterol in vitro, but with lower activity than with GlcCers. Contrary to GlcCer and GalCer, xylosylceramide/XylCer (such as beta-D-xyosyl-(1<->1')-N-acylsphing-4-enine) is not a good substrate for hydrolysis, however it is a good xylose donor for transxylosylation activity to form cholesteryl 3-beta-D-xyloside. Can also metabolize plant glycosyl phytosterols such as glucosylstigmasterol.
Classification
- Family (Pfam)
- PF02055 Glyco_hydro_30, PF17189 Glyco_hydro_30C
- InterPro
- GH, GH30_C, Glyco_hydro_30, Glyco_hydro_30_TIM-barrel
- Functional cluster
- Secreted Growth Factors & Cytokines
Experimental structures · PDB · 58
- 1OGS X-ray 2.00A
- 1Y7V X-ray 2.40A
- 2F61 X-ray 2.50A
- 2J25 X-ray 2.90A
- 2NSX X-ray 2.11A
- 2NT0 X-ray 1.79A
- 2NT1 X-ray 2.30A
- 2V3D X-ray 1.96A
- 2V3E X-ray 2.00A
- 2V3F X-ray 1.95A
- 2VT0 X-ray 2.15A
- 2WCG X-ray 2.30A
- … and 46 more
A predicted model is available from AlphaFold.
Gene Ontology · 39
- GO:0005783 endoplasmic reticulum
- GO:0070062 extracellular exosome
- GO:0005794 Golgi apparatus
- GO:0043202 lysosomal lumen
- GO:0005765 lysosomal membrane
- GO:0005764 lysosome
- GO:0005802 trans-Golgi network
- GO:0008422 beta-glucosidase activity
- GO:0004336 galactosylceramidase activity
- GO:0004348 glucosylceramidase activity
- GO:0046527 glucosyltransferase activity
- GO:0005124 scavenger receptor binding
- GO:0005102 signaling receptor binding
- GO:0050295 steryl-beta-glucosidase activity
- GO:0006914 autophagy
- GO:1901805 beta-glucoside catabolic process
- GO:0009267 cellular response to starvation
- GO:0071356 cellular response to tumor necrosis factor
- GO:0046513 ceramide biosynthetic process
- GO:0008203 cholesterol metabolic process
- GO:0061436 establishment of skin barrier
- GO:0006680 glucosylceramide catabolic process
- GO:0009247 glycolipid biosynthetic process
- GO:1905146 lysosomal protein catabolic process
- GO:0007040 lysosome organization
- GO:0050728 negative regulation of inflammatory response
- GO:0032715 negative regulation of interleukin-6 production
- GO:0043409 negative regulation of MAPK cascade
- GO:1904457 positive regulation of neuronal action potential
- GO:1905165 regulation of lysosomal protein catabolic process
- GO:0016241 regulation of macroautophagy
- GO:0032006 regulation of TOR signaling
- GO:0071548 response to dexamethasone
- GO:0043627 response to estrogen
- GO:0009268 response to pH
- GO:0033574 response to testosterone
- GO:0097066 response to thyroid hormone
- GO:0046512 sphingosine biosynthetic process
- GO:0023021 termination of signal transduction
Disease associations
- late-onset Parkinson disease MONDO:0008199
- Gaucher disease type I MONDO:0009265
- Gaucher disease type II MONDO:0009266
- Gaucher disease type III MONDO:0009267
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome MONDO:0009268
- Gaucher disease perinatal lethal MONDO:0011945
Drugs targeting this protein · 1
- AFEGOSTAT TARTRATE stabiliser
Related proteins · sequence + function similarity
- Lysosomal acid glucosylceramidase 1.00
- Lysosomal acid glucosylceramidase 1.00
- Lysosomal acid glucosylceramidase 0.99
- Lysosomal acid glucosylceramidase 0.97
- Lysosomal acid glucosylceramidase 0.96
- Heparanase 0.73
- Lactase-like protein 0.72
- Hyaluronidase-1 0.72
- Heparanase 0.72
- Lactase-like protein 0.71
- Hyaluronidase-1 0.71
- Sphingomyelin phosphodiesterase 0.71
Co-cited proteins · studied together in the literature
- Lysosomal acid glucosylceramidase 3 shared papers
- Non-lysosomal glucosylceramidase 2 shared papers
- Cytosolic beta-glucosidase 2 shared papers
- Non-lysosomal glucosylceramidase 1 shared papers
- Lysosome membrane protein 2 1 shared papers
- Ceramide glucosyltransferase 1 shared papers
- T-complex protein 1 subunit alpha 1 shared papers
- Auxilin 1 shared papers
- Lysosome membrane protein 2 2 shared papers
- Protein Hook homolog 1 1 shared papers
- Thrombospondin-3 1 shared papers
- Ceramide glucosyltransferase 1 shared papers
Literature · 118 cited papers
- 6-O-alkyl 4-methylumbelliferyl-beta-D-glucosides as selective substrates for GBA1 in the discovery of glycosylated sterols. J. Lipid Res. · 2024
- The molecular mechanism of Gaucher disease caused by compound heterozygous mutations in GBA1 gene. Front. Pediatr. · 2023
- Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model. PLoS ONE · 2021
- Human glucocerebrosidase mediates formation of xylosyl-cholesterol by beta-xylosidase and transxylosidase reactions. J. Lipid Res. · 2021
- Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece. Mol. Genet. Metab. Rep. · 2020
- Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol. J. Biol. Chem. · 2020
- Use of a multiplex ligation-dependent probe amplification method for the detection of deletions/duplications in the GBA1 gene in Gaucher disease patients. Blood Cells Mol. Dis. · 2018
- Progranulin Recruits HSP70 to beta-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease. EBioMedicine · 2016
- Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease. Hum. Mol. Genet. · 2016
- Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular beta-glucosidases. J. Lipid Res. · 2016
- DNAJC6 mutations associated with early-onset Parkinson's disease. Ann. Neurol. · 2016
- Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1. Ann. Hematol. · 2014
- … and 106 more in the literature graph